Instil Bio: Funding, Investors & Team (Oct 2026)
Instil Bio is a cell therapy company developing tumor infiltrating lymphocytes (TIL) for the treatment of solid tumor cancers. TIL are a patient’s own T cells harvested from the patient’s tumor, which are then expanded and reinfused into the patient to target and kill cancer cells. The company is advancing its proprietary manufacturing expertise, technology, and data into clinical trials, including a planned registrational study with its lead candidate and a first-in-human study of its next-generation engineered TIL. The company is led by world-class cell therapy experts and backed by premier global institutional investors. Instil is located in the greater Los Angeles area with additional manufacturing and research facilities in Manchester, UK.
Instil Bio has raised $170M across 1 funding round on record, the most recent an undisclosed round of $170M announced in Aug 2020.
That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Instil Bio Company Profile and Key Stats
Latest funding round on record: Aug 2020.
Instil Bio Funding Rounds
Instil Bio Founders and Leadership Team
No contact details are on record for this team yet.
Instil Bio Funding Compared to Other Biotechnology Startups
Instil Bio's latest round of $170M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Instil Bio in Biotechnology and Dallas
Companies Similar to Instil Bio
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Instil Bio Funding FAQs
What does Instil Bio do?
Instil Bio is a cell therapy company developing tumor infiltrating lymphocytes (TIL) for the treatment of solid tumor cancers. TIL are a patient’s own T cells harvested from the patient’s tumor, which are then expanded and reinfused into the patient to target and kill cancer cells. The company is advancing its proprietary manufacturing expertise, technology, and data into clinical trials, including a planned registrational study with its lead candidate and a first-in-human study of its next-generation engineered TIL. The company is led by world-class cell therapy experts and backed by premier global institutional investors. Instil is located in the greater Los Angeles area with additional manufacturing and research facilities in Manchester, UK.
How much funding has Instil Bio raised?
Instil Bio has raised $170M across 1 round on record. The most recent is an undisclosed round of $170M announced in Aug 2020.
When did Instil Bio last raise funding?
Instil Bio's most recent funding round on record is an undisclosed round of $170M, announced in Aug 2020.
Who is the CEO of Instil Bio?
Bronson Crouch is listed as CEO at Instil Bio.
Where is Instil Bio headquartered?
Instil Bio is based in Dallas, Texas, United States.
How many employees does Instil Bio have?
Instil Bio is in the 101-250 employee band.
How does Instil Bio's funding compare to other Biotechnology startups?
Instil Bio's latest round of $170M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Instil Bio Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Instil Bio is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.